US Stock MarketDetailed Quotes
BMRA Biomerica
- 0.314
- -0.010-2.94%
Close Nov 22 16:00 ET
- 0.314
- 0.0000.00%
Post 20:01 ET
5.28MMarket Cap-848P/E (TTM)
0.340High0.313Low131.73KVolume0.320Open0.324Pre Close42.54KTurnover0.84%Turnover RatioLossP/E (Static)16.82MShares2.13052wk High0.99P/B4.90MFloat Cap0.24252wk Low--Dividend TTM15.61MShs Float23.390Historical High--Div YieldTTM8.25%Amplitude0.170Historical Low0.322Avg Price1Lot Size
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
Biomerica Stock Forum
Biomerica Secures Three Key International Patents for inFoods® Technology to Address GERD, Crohn’s Disease, and Ulcerative Colitis
Biomerica (NASDAQ: BMRA) has secured three key patent allowances in European markets for its inFoods® Technology, targeting GERD, Crohn's Disease, and Ulcerative Colitis. The patents cover major European markets including Germany, UK, France, Italy, Spain, and over 30 other EPO nations. These markets represent significant opportunities: GERD ...
just
Biomerica Secures Three Key International Patents for Infoods® Technology to Address Gerd, Crohn’s Disease, and Ulcerative Colitis
Nasdaq grants Biomerica an additional 180 days to meet listing compliance requirements
They don't seem to know how to sell the news.
The Saudi Food and Drug Authority (Sfda) Approves Biomerica's at Home Psa Screening Test to Detect Early Signs of Prostate Cancer
Biomerica Launches At-Home Sample Collection for inFoods® IBS, Significantly Expanding Access for Millions of IBS Sufferers
Biomerica (Nasdaq: BMRA) has launched an at-home sample collection system for its inFoods® IBS diagnostic test, enhancing patient convenience and expanding access to millions of IBS sufferers. Using a simple finger-stick method, patients can now self-collect blood samples at home, eliminating the need for healthcare facility visits. This innovation ...
biggest but signal I've ever seen
No comment yet